Neurothrombectomy Trial Results: Stroke Systems, Not Just Devices, Make the Difference
- 24 September 2015
- journal article
- Published by SAGE Publications in International Journal of Stroke
- Vol. 10 (7), 990-993
- https://doi.org/10.1111/ijs.12614
Abstract
The overwhelming benefit demonstrated in the four recent randomized trials comparing intra-arterial therapies to medical management alone will have a transformative effect on the emergent management of strokes throughout the world. New generation neurothrombectomy devices were critical to trial success, but not the sole driver of patient outcomes in these trials. Patients in the positive trials were treated at hospitals with complex, efficient, resource-rich, team-based stroke systems in place. To ensure attainment of trial results in actual practice, patients should receive treatment at facilities certified as having the resources, personnel, organization, and continuous quality improvement processes characteristic of trial centers. It is our hope that, through greater education initiatives, robust resource investment, and developing quality-based certification processes, the results demonstrated by these trials may be extrapolated to greater numbers of centers – in turn allowing greater access for patients to high-quality, advanced stroke care.Keywords
This publication has 29 references indexed in Scilit:
- Randomized Assessment of Rapid Endovascular Treatment of Ischemic StrokeThe New England Journal of Medicine, 2015
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging SelectionThe New England Journal of Medicine, 2015
- A Randomized Trial of Intraarterial Treatment for Acute Ischemic StrokeThe New England Journal of Medicine, 2015
- Endovascular therapy for acute ischemic stroke is indicated and evidence based: a position statementJournal of NeuroInterventional Surgery, 2014
- A Trial of Imaging Selection and Endovascular Treatment for Ischemic StrokeThe New England Journal of Medicine, 2013
- Endovascular Therapy after Intravenous t-PA versus t-PA Alone for StrokeThe New England Journal of Medicine, 2013
- Endovascular Treatment for Acute Ischemic StrokeThe New England Journal of Medicine, 2013
- Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trialThe Lancet, 2012
- Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trialThe Lancet, 2012
- The Impact of Recanalization on Ischemic Stroke OutcomeStroke, 2007